Skip to main content
. 2015 Jan 27;59(2):914–922. doi: 10.1128/AAC.03781-14

TABLE 1.

MICs of anti-ftsZ PLNA and antibiotics in MSSA and MRSA isolates in MH broth cultures

PLNA or antibiotic MIC of strain:a
ATCC 29213 Mu50 WHO-2 MRSA01 MRSA02 MRSA03 MRSA04 MRSA05 MRSA06 MRSA07
PLNA787 (μM) 3.13 1.56 12.5 6.25 3.13 6.25 12.5 12.5 6.25 3.13
Free LNA787 (μM) >50 >50 >50 >50 >50 >50 >50 >50 >50 >50
Free (KFF)3K (μM) >50 >50 >50 >50 >50 >50 >50 >50 >50 >50
Scrambled PLNA (μM) >50 >50 >50 >50 >50 >50 >50 >50 >50 >50
OXA (μg/ml) 0.5 (S) 256 (R) 1,024 (R) 1,024 (R) 256 (R) 512 (R) 1,024 (R) 1,024 (R) 256 (R) 128 (R)
AMP (μg/ml) 1 (S) 256 (R) 1,024 (R) 1,024 (R) 256 (R) 512 (R) 1,024 (R) 1,024 (R) 256 (R) 128 (R)
CAZ (μg/ml) 8 (S) 512 (R) 256 (R) 128 (R) 256 (R) 16 (I) 8 (S) 512 (R) 128 (R) 64 (R)
LVX (μg/ml) 0.5 (S) 128 (R) 128 (R) 256 (R) 32 (R) 2 (I) 16 (R) 256 (R) 128 (R) 64 (R)
a

Data are derived from 3 independent experiments. OXA, oxacillin; AMP, ampicillin; CAZ, ceftazidime; LVX, levofloxacin; MH, Mueller-Hinton; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; PLNA, peptide-locked nucleic acid; R, resistant; I, intermediate; S, susceptible.